Phase 2 Proof-of-Concept Trial Testing the PARP Inhibitor Niraparib in Patients with Pancreatic Cancer Harboring Deficiencies in Homologous Recombination DNA Repair
NOT ENROLLING
Trial ID:
NCT03601923 Protocol # :
18-207
Conditions
Pancreatic Cancer
Phase
II
Disease Sites
Pancreas
Principal Investigator
Cleary, James, M
Site Investigator
Clark, Jeffrey, W.
Peters, Mary Linton, B.
Site Research Nurses
Connelly, Alexandra
D'Alessandro, Christine, M.
Furtado, Mollie, E.
Germon, Victoria
Graham, Christopher
Johnston, Joanna, L.
Lynch, Patricia
Nicolazzo, Karicaty
Ritterband, Lauren
Sawin, Mark
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-207
18-207